LND vs. AVO, FDP, TED, CUSN, FAR, ATM, ZNWD, MKA, ARCM, and GSP
Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Cornish Metals (CUSN), Ferro-Alloy Resources (FAR), Andrada Mining (ATM), Zinnwald Lithium (ZNWD), Mkango Resources (MKA), Arc Minerals (ARCM), and Gensource Potash (GSP).
Landore Resources vs.
Landore Resources (LON:LND) and Advanced Oncotherapy (LON:AVO) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations.
Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.
3.2% of Landore Resources shares are held by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are held by institutional investors. 39.6% of Landore Resources shares are held by company insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Landore Resources' average media sentiment score of 0.00 equaled Advanced Oncotherapy'saverage media sentiment score.
Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.
Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.
Landore Resources has a beta of -0.15, meaning that its stock price is 115% less volatile than the S&P 500. Comparatively, Advanced Oncotherapy has a beta of 0.06, meaning that its stock price is 94% less volatile than the S&P 500.
Summary
Advanced Oncotherapy beats Landore Resources on 8 of the 10 factors compared between the two stocks.
Get Landore Resources News Delivered to You Automatically
Sign up to receive the latest news and ratings for LND and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Landore Resources Competitors List
Related Companies and Tools
This page (LON:LND) was last updated on 2/22/2025 by MarketBeat.com Staff
